Health
Regeneron suspends COVID-19 antibody trial among sickest patients – Gulf News
Move follows recommendation from independent committee which assesses results
A Regeneron Pharmaceuticals scientist works in the company’s Infectious disease lab in New York state on an experimental coronavirus antibody drug.
Image Credit: Regeneron / via AP file
Washington: US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its COVID-19 antibody treatment among the sickest patients who require high-flow oxygen or are on ventilators.
The move follows a recommendation from an independent data monitoring committee (IDMC) which assesses the…
-
Noosa News14 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News24 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland
-
General9 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News23 hours agoMissing man, Maroochydore – Queensland Police News